Phenotypic characterization of CADASIL patients with the Arg332Cys mutation in the NOTCH3
Abstract
BACKGROUND: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary vascular disease caused by mutations in NOTCH3, that are primarily localized in exons 4, 3, and 11. The Arg332Cys mutation in exon 6 has been rarely reported in patients with CADASIL.
METHODS: A case study and the results of a comprehensive systemic search of the PubMed database, using the keywords "CADASIL", "Arg332Cys", "R332C", and "exon 6", are reported. The results obtained, combined with the data obtained from the largest published case series on CADASIL, the clinical and imaging characteristics of patients with the Arg332Cys mutation, were compared and analyzed.
RESULTS: A 48-year-old woman with a rare Arg332Cys mutation in exon 6 of NOTCH3, who presented with rapidly developing dementia and recurrent ischemic stroke, was investigated herein. Magnetic resonance imaging (MRI) revealed abnormal signals in the cerebral white matter, bilateral thalamus, internal and external capsules, basal ganglia, corpus callosum, and brainstem. Literature review identified an additional 21 individuals, comprising 11 Europeans and 10 Asians, with the Arg332Cys mutation; of these identified individuals, clinical data was available for 2 Italian and 9 Asian patients. Analysis of the clinical characteristics of the 11 patients and the patient we reported showed that their mean age at disease onset was 37.82±9.36 years, much earlier than 57.0±9.36 years reported…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 21 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.